Histotechnology
[Hisztotechnológia]
EPTIS Ringversuch Nr. 1278475 | Letze Änderung 2026-03-19 | URL: https://www.eptis.bam.de/pts1278475 https://www.eptis.bam.de/pts1278475
| Name des Anbieters | |||||||
| Name des Anbieters | QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. | ||||||
| Ansässig in | Hungary | ||||||
| Sprache(n) | English, Hungarian | ||||||
| Anmerkungen | Unstained paraffin slides are sent to the participants. Task: routine staining and detection of immunohistochemical marker molecules on the distributed (2-2 unstained slides per test/per survey ) and in-house created slides. Reporting of results: the technical details of the stained sections and the methods are to be sent electronically via Internet. The evaluations and the certificates are available electronically, too. The stained slides must be sent back physically to QualiCont! The following slides are sent in each survey: HT/01 – Required sample in every survey Haematoxylin-eosin stain – in-house (slide taken from the archive, registered on the number given by QualiCont) HT/02 – Slides provided by QualiCont in every survey Haematoxylin-eosin stain – QualiCont (slide sent by QualiCont) HT/03 – Slides provided by QualiCont, various stains in every survey Special-stain – QualiCont (1 from the list below): PAS, Gram, Reticulin, Giemsa, Elastic fibers, Berlin-blue, Trichrome, Ziehl-Neelsen, Amyloid, Grocott QualiCont has had accredited status as the QualiCont as a Proficiency Test Provider complies with the criteria of MSZ EN ISO/IEC 17043:2010 standard since 26 March 2014. The QualiCont has been accredited according to the MSZ EN ISO/IEC 17043:2023 standard since 18 December 2025. Our Company is a Proficiency Testing Provider Organisation accredited by NAH (National Accreditation Authority) under the NAH-8-0002/2023 registration number. As the result of the accreditation process performed by NAH, our Company has accredited status until 9 March 2028. | ||||||
| Klassifizierung | |||||||
| Produktgruppen |
Health care / medical devices
Human test material |
||||||
| Prüfgebiete |
Medical analysis
|
||||||
| Technische Einzelheiten | |||||||
|
|||||||
| Ringversuchsziele | |||||||
| Zielgruppe des Ringversuchs | In vitro medical laboratories | ||||||
| Relevante Rechtsvorschriften oder Normen | ISO 15189 – Medical laboratories – Requirements for quality and competence ISO/TS20658:2017 – Medical laboratories – Requirements for collection, transport, receipt and handling of samples VIM3 – Vocabulaire International de Métrologie WHO – Guidance on regulations for the Transport of Infectious Substances | ||||||
| Weitere Ziele | validation of testing methods | ||||||
| Teilnehmerzahl | |||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) | |||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | |||||||
| Kosten | |||||||
| Teilnahmegebühr | on demand | ||||||
| Regelmässig durchgeführt | Ja (four times a year) | ||||||
| Der Ringversuch wird durchgeführt seit | |||||||
| Kontaktdaten des Anbieters | |||||||
| Anbieter | Kontaktperson | ||||||
|
QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd.
Feketesas u. 19-21. I/7 6720 Szeged Hungary Telefon: +36 30 462 5864 Fax: Web: http://www.qualicont.com/qc/index_en.html http://www.qualicont.com/qc/index_en.html |
Ms. Eszter Mezey
Telefon: +36 30 462 5864 Fax: E-Mail: mail@qualicont.com mail@qualicont.com |
||||||